Industry Update View All
Improving Quality of Life in Parkinson’s Disease: Safinamide’s Impact beyond Motor Symptoms

Case Presentation A 72-year-old man, previously diagnosed with Parkinson’s disease (PD) 10 years ago, presented with persistent end-of-dose resting tremor despite regular follow-up at a public hospital. He was partially dependent in his activi...

Dr. Mohsin RoshanApr 11, 2025
Advancing HCV Elimination in Marginalised Communities: Strategies and Challenges

The availability of safe and effective oral direct-acting antivirals (DAAs) has paved the path to eliminating hepatitis C (HCV) infection. Accordingly, the World Health Organisation (WHO) addressed a global target in 2016 for the elimination of HCV ...

Dr. Roy LauApr 11, 2025
Innovative Post-Exposure Prophylaxis Treatment of Rabies by Monoclonal Antibody Cocktail

Rabies is a zoonotic disease caused by an RNA virus from the family Rhabdoviridae, genus Lyssavirus. 1 Currently, rabies is prevalent in over 100 countries and regions worldwide. 2 When rabies virus reaches the brain, the damage causes neurological ...

Dr. Feng XueApr 11, 2025
FeaturedView All